These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38262002)

  • 1. Poor Glycemic Control Is Associated With More Rapid Kidney Function Decline After the Onset of Diabetic Kidney Disease.
    Shah HS; McGill JB; Hirsch IB; Wu C; Galecki A; de Boer IH; Mauer M; Doria A
    J Clin Endocrinol Metab; 2024 Jul; 109(8):2124-2135. PubMed ID: 38262002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.
    Afkarian M; Polsky S; Parsa A; Aronson R; Caramori ML; Cherney DZ; Crandall JP; de Boer IH; Elliott TG; Galecki AT; Goldfine AB; Haw JS; Hirsch IB; Karger AB; Lingvay I; Maahs DM; McGill JB; Molitch ME; Perkins BA; Pop-Busui R; Pragnell M; Rosas SE; Rossing P; Senior P; Sigal RJ; Spino C; Tuttle KR; Umpierrez GE; Wallia A; Weinstock RS; Wu C; Mauer M; Doria A;
    Diabetes Care; 2019 Aug; 42(8):1454-1463. PubMed ID: 31186299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual deterioration of renal function in hypertensive patients with and without diabetes.
    Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
    Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
    Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
    J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR: A Post Hoc Analysis of the CREDENCE Trial.
    van der Hoek S; Jongs N; Oshima M; Neuen BL; Stevens J; Perkovic V; Levin A; Mahaffey KW; Pollock C; Greene T; Wheeler DC; Jardine MJ; Heerspink HJL
    Clin J Am Soc Nephrol; 2023 Jun; 18(6):748-758. PubMed ID: 36999981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.
    Zoppini G; Targher G; Chonchol M; Ortalda V; Negri C; Stoico V; Bonora E
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):401-8. PubMed ID: 22282481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated baseline glomerular filtration rate (GFR) is independently associated with a more rapid decline in renal function of patients with type 1 diabetes.
    Thomson HJ; Ekinci EI; Radcliffe NJ; Seah JM; MacIsaac RJ; Jerums G; Premaratne E
    J Diabetes Complications; 2016 Mar; 30(2):256-61. PubMed ID: 26794645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
    Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
    BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic and dual effects of glycated hemoglobin on estimated glomerular filtration rate in type 2 diabetic outpatients.
    Lee CL; Li TC; Lin SY; Wang JS; Lee IT; Tseng LN; Song YM; Tsai SF; Sheu WH
    Am J Nephrol; 2013; 38(1):19-26. PubMed ID: 23817017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term glycemic variability on estimated glomerular filtration rate decline among patients with type 2 diabetes mellitus: Insights from the Diabetic Nephropathy Cohort in Singapore.
    Low S; Lim SC; Yeoh LY; Liu YL; Liu JJ; Fun S; Su C; Zhang X; Subramaniam T; Sum CF
    J Diabetes; 2017 Oct; 9(10):908-919. PubMed ID: 27935225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Sone H; Ishibashi S; Matsunaga S; Ohashi Y; Akanuma Y; Haneda M; Katayama S
    J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.
    Ceriello A; De Cosmo S; Rossi MC; Lucisano G; Genovese S; Pontremoli R; Fioretto P; Giorda C; Pacilli A; Viazzi F; Russo G; Nicolucci A;
    Diabetes Obes Metab; 2017 Nov; 19(11):1570-1578. PubMed ID: 28432733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Autonomic Neuropathy and Risk of Kidney Function Decline in Type 1 and Type 2 Diabetes: Findings From the PERL and ACCORD Cohorts.
    Tang Y; Ang L; Jaiswal M; Dillon BR; Esfandiari NH; Shah HS; Spino C; Plunkett C; Perkins BA; Pop-Busui R; Doria A
    Diabetes; 2024 May; 73(5):751-762. PubMed ID: 37467433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N; Russell J; El Nahas M
    Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial.
    Bjornstad P; Nehus E; El Ghormli L; Bacha F; Libman IM; McKay S; Willi SM; Laffel L; Arslanian S; Nadeau KJ;
    Am J Kidney Dis; 2018 Jan; 71(1):65-74. PubMed ID: 29157731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.
    Bjornstad P; Pyle L; Kinney GL; Rewers M; Johnson RJ; Maahs DM; Snell-Bergeon JK
    J Diabetes Complications; 2017 Feb; 31(2):369-374. PubMed ID: 27368123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria.
    Vistisen D; Andersen GS; Hulman A; Persson F; Rossing P; Jørgensen ME
    Diabetes Care; 2019 Oct; 42(10):1886-1894. PubMed ID: 31221677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.
    Mottl AK; Buse JB; Ismail-Beigi F; Sigal RJ; Pedley CF; Papademetriou V; Simmons DL; Katz L; Mychaleckyj JC; Craven TE
    Clin J Am Soc Nephrol; 2018 Nov; 13(11):1693-1702. PubMed ID: 30361335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function as an effect modifier of intensive glucose control in delaying cognitive function decline among individuals with type 2 diabetes: A revisit to the ACCORD MIND trial.
    Li P; Kianmehr H; Guan D; Kulshreshtha A; Narayan KMV; Ali MK; Umpierrez GE; Hu X; Fonseca VA; Shi L; Shao H
    Diabetes Obes Metab; 2024 Sep; 26(9):3958-3968. PubMed ID: 38962812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial.
    Wexler DJ; de Boer IH; Ghosh A; Younes N; Bebu I; Inzucchi SE; McGill JB; Mudaliar S; Schade D; Steffes MW; Tamborlane WV; Tan MH; Ismail-Beigi F;
    JAMA Intern Med; 2023 Jul; 183(7):705-714. PubMed ID: 37213109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.